Cargando…
KRAS mutations as essential promoters of lymphangiogenesis via extracellular vesicles in pancreatic cancer
Kirsten rat sarcoma virus (KRAS) gene mutations are present in more than 90% of pancreatic ductal adenocarcinomas (PDACs). KRAS(G12D) is the most frequent alteration, promoting preneoplastic lesions and associating with a more aggressive phenotype. These tumors possess increased intratumoral lymphat...
Autores principales: | Pirlog, Radu, Calin, George A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282924/ https://www.ncbi.nlm.nih.gov/pubmed/35838046 http://dx.doi.org/10.1172/JCI161454 |
Ejemplares similares
-
KRAS mutant–driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer
por: Luo, Yuming, et al.
Publicado: (2022) -
Role of Extracellular Vesicles on Cancer Lymphangiogenesis and Lymph Node Metastasis
por: Wang, Linlin, et al.
Publicado: (2021) -
Morphological and Molecular Characterization of KRAS G12C-Mutated Lung Adenocarcinomas
por: Pirlog, Radu, et al.
Publicado: (2022) -
Macrophage efferocytosis with VEGFC and lymphangiogenesis: rescuing the broken heart
por: D’Amore, Patricia A., et al.
Publicado: (2022) -
KRAS-driven ROS promote malignant transformation
por: Suh, Yongjoon, et al.
Publicado: (2015)